Related Experiment Video
Updated: Dec 28, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network
Simon Dirmeier1,2, Christopher Dächert3,4, Martijn van Hemert5
1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
This study introduces a new method to find common host factors essential for various viruses, identifying UBC, PLCG1, and DYRK1B as key targets for broad-spectrum antiviral drug development.
Area of Science:
- Virology
- Genetics
- Computational Biology
Background:
- Genetic screens identify host factors crucial for pathogen replication.
- Previous studies focused on single pathogens and limited gene subsets.
- Identifying pan-pathogen host factors is vital for broad-spectrum antiviral therapies.
Purpose of the Study:
- To develop a novel computational procedure for identifying host factors common to diverse viral replication.
- To apply this method to RNA interference (RNAi) screening data from multiple viruses.
- To discover and validate novel host factors influencing viral life cycles.
Main Methods:
- A two-stage procedure combining random effects models and Markov random walks on a functional interaction network.
- Joint analysis of multiple RNAi screens to infer candidate host genes.
- Network-based analysis to incorporate pathway information and smooth effect sizes.
Main Results:
- The procedure identified novel host factors, including UBC, PLCG1, and DYRK1B, crucial for viral replication.
- Applied to RNAi data from Hepatitis C virus, Chikungunya virus, Dengue virus, and SARS-CoV.
- Experimental validation confirmed the role of identified host factors in pathogen replication.
Conclusions:
- The novel computational approach effectively identifies pan-pathogen host factors.
- UBC, PLCG1, and DYRK1B represent promising targets for broad-spectrum antiviral drug development.
- This method advances the discovery of host-directed antivirals.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
06:02Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018